SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-101597
Filing Date
2023-09-18
Accepted
2023-09-18 16:20:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2326323d2_defa14a.htm DEFA14A 11881
  Complete submission text file 0001104659-23-101597.txt   13121
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35963 | Film No.: 231261435
SIC: 2834 Pharmaceutical Preparations